Visteon (VC) Guides FY12 Sales, CapEx, EBITDA
Tweet
Share
E-mailGet Alerts VC Hot Sheet
Join SI Premium – FREE
In a From 8-K Wednesday morning, Visteon (NYSE: VC) offered some guidance in a slideshow presentation: sees FY12 product sales of $7.1-$7.8 billion, which compares to the Street estimate of $7.91 billion. Sees capex of about $250 million. Sees adj-EBITDA of $650-$690 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix (NFLX) Tops Q2 EPS by 1c, Offers Guidance
- Johnson & Johnson (JNJ) Tops Q2 EPS by 4c; raises guidance
- STAAR Surgical Q2 2026 net sales expected to exceed $90 million
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
